Qing Che Zuraw

Insider Reports History

Location
Cambridge, MA
Signature
Adi Osovsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Qing Che Zuraw:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vor Biopharma Inc. Chief Development Officer Common Stock 937,080 $140,562 $0.1500 17 Jul 2025 Direct
Vor Biopharma Inc. Chief Development Officer Employee Stock Option (right to buy) 218,652 05 Dec 2025 Direct

Insider Reports Filed by Qing Che Zuraw

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VOR Vor Biopharma Inc. 05 Dec 2025 2 $0 4 Chief Development Officer 09 Dec 2025, 08:00
VOR Vor Biopharma Inc. 17 Jul 2025 2 $0 4 Chief Development Officer 30 Jul 2025, 16:03
VOR Vor Biopharma Inc. 17 Jul 2025 0 $0 3 Chief Development Officer 30 Jul 2025, 16:02